Eversept Partners, LP
- SEC CIK
- 0001697013
- Latest filing
- Aug 14, 2026
Holdings in Q4 2021
Holdings as of Dec 31, 2021, filed Nov 8, 2023. Long positions only; changes compare share counts with Q3 2021.
- Positions
- 90
- +2 vs. Q3 2021
- Portfolio value
- $1.20B
- −$44.5M (−3.6%) vs. Q3 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| HZNPHorizon Therapeutics Public Ltd Co | SHS | 833,750 | $89.8M | 7.5% | +199,080+31.4% | Added | History |
| CYHCommunity Health Systems Inc | COM | 6,389,538 | $85.0M | 7.1% | +401,375+6.7% | Added | History |
| UTHRUnited Therapeutics Corp | COM | 391,920 | $84.7M | 7.0% | −52,551−11.8% | Reduced | History |
| DHRDanaher Corp | Stock | 170,053 | $56.0M | 4.7% | +22,115+14.9% | Added | History |
| AZNAstraZeneca PLC | SPONSORED ADR | 949,224 | $55.3M | 4.6% | +58,416+6.6% | Added | History |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 403,678 | $54.3M | 4.5% | −41,525−9.3% | Reduced | History |
| AVTRAvantor, Inc. | COM | 1,125,465 | $47.4M | 3.9% | −166,549−12.9% | Reduced | History |
| BHVNBiohaven Ltd. | COM | 315,129 | $43.4M | 3.6% | +315,129 | New | History |
| ARK ETF Tr00214Q302 | GENOMIC REV ETF | 664,484 | $40.7M | 3.4% | −25,017−3.6% | Reduced | – |
| NVSTEnvista Holdings Corp | COM | 849,298 | $38.3M | 3.2% | +38,417+4.7% | Added | History |
| AMRNAmarin Corp PLC | SPONS ADR NEW | 10,573,302 | $35.6M | 3.0% | −1,031,688−8.9% | Reduced | History |
| MCKMcKesson Corp | Stock | 136,111 | $33.9M | 2.8% | −25,597−15.8% | Reduced | History |
| AMRXAmneal Pharmaceuticals, Inc. | COM STK CL A | 6,440,572 | $30.9M | 2.6% | −409,262−6.0% | Reduced | History |
| GSKGSK plc | SPONSORED ADR | 567,205 | $25.0M | 2.1% | +165,551+41.2% | Added | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 592,478 | $22.9M | 1.9% | +592,478 | New | History |
| OCDXOrtho Clinical Diagnostics Holdings plc | ORD SHS | 886,140 | $19.0M | 1.6% | −28,846−3.2% | Reduced | History |
| RCMR1 RCM Holdco Inc. | COM | 733,132 | $18.7M | 1.6% | −31,648−4.1% | Reduced | History |
| CNCCentene Corp | Stock | 224,613 | $18.5M | 1.5% | +83,506+59.2% | Added | History |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 2,301,498 | $18.4M | 1.5% | −1,253,306−35.3% | Reduced | History |
| ICLRIcon PLC | COM | 51,867 | $16.1M | 1.3% | −20,044−27.9% | Reduced | History |
| ELVElevance Health, Inc. | Stock | 34,294 | $15.9M | 1.3% | +2,666+8.4% | Added | History |
| FATEFate Therapeutics Inc | COM | 254,790 | $14.9M | 1.2% | −6,105−2.3% | Reduced | History |
| HQYHealthequity, Inc. | COM | 333,352 | $14.7M | 1.2% | +218,974+191.4% | Added | History |
| LHLabcorp Holdings Inc. | COM NEW | 45,522 | $14.3M | 1.2% | −82,789−64.5% | Reduced | History |
| HUMHumana Inc | Stock | 27,382 | $12.7M | 1.1% | +3,299+13.7% | Added | History |
| HCAHCA Healthcare, Inc. | COM | 49,094 | $12.6M | 1.0% | +10,728+28.0% | Added | History |
| ITCIIntra-Cellular Therapies, Inc. | COM | 231,787 | $12.1M | 1.0% | +1,043+0.5% | Added | History |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 70,240 | $11.9M | 1.0% | +11,007+18.6% | Added | History |
| IONSIonis Pharmaceuticals Inc | COM | 384,789 | $11.7M | 1.0% | −65,712−14.6% | Reduced | History |
| ARK Innovation ETF00214Q104 | ETF | 119,118 | $11.3M | 0.9% | +84,118+240.3% | Added | – |
| NSTGNS Wind Down Co., Inc. | COM | 265,695 | $11.2M | 0.9% | +97,027+57.5% | Added | History |
| GHGuardant Health, Inc. | COM | 100,334 | $10.0M | 0.8% | −270.0% | Reduced | History |
| MGLNMagellan Health Inc | COM NEW | 104,700 | $9.95M | 0.8% | 00.0% | Unchanged | History |
| EXELExelixis, Inc. | COM | 535,700 | $9.79M | 0.8% | +19,393+3.8% | Added | History |
| NTRANatera, Inc. | COM | 102,071 | $9.53M | 0.8% | −10,118−9.0% | Reduced | History |
| Taro Pharmaceutical Inds LtdM8737E108 | SHS | 181,151 | $9.08M | 0.8% | +1,785+1.0% | Added | – |
| QGENQiagen N.V. | SHS NEW | 162,534 | $9.03M | 0.8% | +19,425+13.6% | Added | History |
| ZGNXZogenix, Inc. | COM NEW | 550,966 | $8.95M | 0.7% | −223,625−28.9% | Reduced | History |
| SYNHSyneos Health, Inc. | CL A | 85,612 | $8.79M | 0.7% | +85,612 | New | History |
| IRTCiRhythm Holdings, Inc. | COM | 73,169 | $8.61M | 0.7% | −40,685−35.7% | Reduced | History |
| PODDInsulet Corp | Stock | 30,172 | $8.03M | 0.7% | +30,172 | New | History |
| BIIBBiogen Inc. | COM | 33,041 | $7.93M | 0.7% | +33,041 | New | History |
| ARGXArgenx SE | SPONSORED ADR | 21,496 | $7.53M | 0.6% | +15,750+274.1% | Added | History |
| CERNCERNER Corp | COM | 77,543 | $7.22M | 0.6% | +77,543 | New | History |
| LQDALiquidia Corp | COM NEW | 1,447,898 | $7.05M | 0.6% | +518,849+55.8% | Added | History |
| IQVIQVIA Holdings Inc. | Stock | 24,618 | $6.95M | 0.6% | +17,828+262.6% | Added | History |
| XENEXenon Pharmaceuticals Inc. | COM | 209,519 | $6.55M | 0.5% | +209,519 | New | History |
| ANABAnaptysbio, Inc | COM | 182,612 | $6.35M | 0.5% | +104,558+134.0% | Added | History |
| RVTYRevvity, Inc. | COM | 30,869 | $6.21M | 0.5% | −16,212−34.4% | Reduced | History |
| SIBNSI-BONE, Inc. | COM | 258,094 | $5.73M | 0.5% | +108,094+72.1% | Added | History |
| NVRONevro Corp | COM | 66,074 | $5.36M | 0.4% | +66,074 | New | History |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 63,163 | $5.31M | 0.4% | +63,163 | New | History |
| AUPHAurinia Pharmaceuticals Inc. | COM | 201,384 | $4.61M | 0.4% | +201,384 | New | History |
| VRDNViridian Therapeutics, Inc. | COM | 194,589 | $3.85M | 0.3% | +34,589+21.6% | Added | History |
| MRVIMaravai Lifesciences Holdings, Inc. | COM CL A | 87,795 | $3.68M | 0.3% | −240,015−73.2% | Reduced | History |
| ISRGIntuitive Surgical Inc | COM NEW | 9,825 | $3.53M | 0.3% | +390+4.1% | AddedConverted for a 3-for-1 split | History |
| DXCMDexcom Inc | COM | 6,401 | $3.44M | 0.3% | 00.0% | Unchanged | History |
| PBYIPuma Biotechnology, Inc. | COM | 1,117,898 | $3.40M | 0.3% | +719,958+180.9% | Added | History |
| LXRXLexicon Pharmaceuticals, Inc. | COM NEW | 797,694 | $3.14M | 0.3% | −75,000−8.6% | Reduced | History |
| AAgilent Technologies, Inc. | COM | 19,431 | $3.10M | 0.3% | +771+4.1% | Added | History |
| Curevac N VN2451R105 | COM | 85,017 | $2.92M | 0.2% | +85,017 | New | – |
| GRTSGritstone bio, Inc. | COM | 170,125 | $2.19M | 0.2% | +170,125 | New | History |
| MRTXMirati Therapeutics, Inc. | COM | 14,840 | $2.18M | 0.2% | +5,485+58.6% | Added | History |
| KRTXKaruna Therapeutics, Inc. | COM | 15,934 | $2.09M | 0.2% | −9,066−36.3% | Reduced | History |
| AUTLAutolus Therapeutics plc | SPON ADS | 401,540 | $2.08M | 0.2% | +3,466+0.9% | Added | History |
| SNYSanofi | SPONSORED ADR | 38,672 | $1.94M | 0.2% | −220,456−85.1% | Reduced | History |
| ESTAEstablishment Labs Holdings Inc. | COM | 25,137 | $1.70M | 0.1% | +25,137 | New | History |
| SRGASurgalign Holdings, Inc. | COM | 1,918,743 | $1.37M | 0.1% | −1,589,793−45.3% | Reduced | History |
| ADAPYAdaptimmune Therapeutics PLC | SPONDS ADR | 348,716 | $1.31M | 0.1% | −96,171−21.6% | Reduced | History |
| RGENRepligen Corp | COM | 4,584 | $1.21M | 0.1% | +182+4.1% | Added | History |
| TECXTectonic Therapeutic, Inc. | COM | 304,989 | $1.17M | 0.1% | −54,491−15.2% | Reduced | History |
| MYOMyomo, Inc. | COM NEW | 150,000 | $1.03M | 0.1% | 00.0% | Unchanged | History |
| VCRAVocera Communications, Inc. | COM | 14,970 | $970.7K | 0.1% | +14,970 | New | History |
| MISTMilestone Pharmaceuticals Inc. | COM | 147,165 | $963.9K | 0.1% | +33,568+29.6% | Added | History |
| ENSGEnsign Group, Inc | COM | 10,397 | $873.5K | 0.1% | 00.0% | Unchanged | History |
| HSKAHeska Corp | COM RESTRC NEW | 4,525 | $825.8K | 0.1% | 00.0% | Unchanged | History |
| ACIUAC Immune SA | SHS | 153,380 | $759.2K | 0.1% | −68,369−30.8% | Reduced | History |
| ASMBAssembly Biosciences, Inc. | COM | 310,000 | $722.3K | 0.1% | −40,000−11.4% | Reduced | History |
| LogicBio Therapeutics, Inc.54142F102 | COM | 291,101 | $672.4K | 0.1% | −58,818−16.8% | Reduced | – |
| KRSAKorsana Biosciences, Inc. | COM | 371,955 | $639.8K | 0.1% | 00.0% | Unchanged | History |
| MRUSMerus N.V. | COM | 19,000 | $604.2K | 0.1% | +19,000 | New | History |
| ORTXOrchard Therapeutics plc | ADS | 419,581 | $553.8K | <0.1% | −150,000−26.3% | Reduced | History |
| ELDNEledon Pharmaceuticals, Inc. | COM | 114,008 | $502.8K | <0.1% | 00.0% | Unchanged | History |
| GOSSGossamer Bio, Inc. | COM | 39,910 | $451.4K | <0.1% | −110,000−73.4% | Reduced | History |
| SNDASonida Senior Living, Inc. | COM | 15,209 | $433.3K | <0.1% | +15,209 | New | History |
| MREOMereo BioPharma Group plc | SPON ADS | 259,470 | $415.2K | <0.1% | −640,099−71.2% | Reduced | History |
| BKDBrookdale Senior Living Inc. | COM | 79,146 | $408.4K | <0.1% | +79,146 | New | History |
| FSTXF-star Therapeutics, Inc. | COM | 49,933 | $250.7K | <0.1% | 00.0% | Unchanged | History |
| CBIOCrescent Biopharma, Inc. | COM | 100,000 | $144.0K | <0.1% | +100,000 | New | History |
| MRKMerck & Co., Inc. | Stock | 19,456 | – | – | +19,456 | New | History |
Options (17)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| Invesco QQQ Trust Series I46090E103 | ETF | $114.0M | – |
| GSKGSK plc | SPONSORED ADR | – | $66.3M |
| AZNAstraZeneca PLC | SPONSORED ADR | – | $33.3M |
| iShares Russell 2000 ETF464287655 | ETF | $27.8M | – |
| iShares Russell 2000 Growth ETF464287648 | ETF | $26.4M | – |
| VRTXVertex Pharmaceuticals Inc | Stock | – | $20.7M |
| CYHCommunity Health Systems Inc | COM | – | $17.0M |
| ARK ETF Tr00214Q302 | GENOMIC REV ETF | – | $14.9M |
| State Street SPDR S&P Biotech ETF78464A870 | ETF | – | $12.7M |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | – | $7.71M |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | – | $7.54M |
| MRKMerck & Co., Inc. | Stock | – | $3.73M |
| PGNYProgyny, Inc. | COM | $2.52M | – |
| ACADAcadia Pharmaceuticals Inc | COM | – | $1.97M |
| UTHRUnited Therapeutics Corp | COM | – | $1.64M |
| JYNTJOINT Corp | COM | $361.3K | – |
| MNKDMannkind Corp | COM NEW | – | $218.5K |
Sold out since Q3 2021 (17)
Positions held at the end of Q3 2021 that are gone from this filing.
| Security | Class | Shares in Q3 2021 | Value in Q3 2021 | % of portfolio in Q3 2021 | History |
|---|---|---|---|---|---|
| XLRNAcceleron Pharma Inc | COM | 349,494 | $60.1M | 4.8% | History |
| BMYBristol Myers Squibb Co | Stock | 464,801 | $27.8M | 2.2% | History |
| CTLTCatalent, Inc. | COM | 184,299 | $24.5M | 2.0% | History |
| MASIMasimo Corp | COM | 67,000 | $18.1M | 1.5% | History |
| GOCOGoHealth, Inc. | COM CL A | 1,261,723 | $6.35M | 0.5% | History |
| HRCHill-Rom Holdings, Inc. | COM | 30,000 | $4.50M | 0.4% | History |
| EVHEvolent Health, Inc. | CL A | 100,170 | $3.11M | 0.2% | History |
| MORFMorphic Holding, Inc. | COM | 43,600 | $2.47M | 0.2% | History |
| OMOutset Medical, Inc. | COM | 47,500 | $2.35M | 0.2% | History |
| HSTMHealthstream Inc | COM | 77,812 | $2.22M | 0.2% | History |
| DNTHDianthus Therapeutics, Inc. | COM | 198,879 | $1.45M | 0.1% | History |
| AKYAAkoya Biosciences, Inc. | COM | 91,568 | $1.28M | 0.1% | History |
| AMNAmn Healthcare Services Inc | COM | 10,000 | $1.15M | 0.1% | History |
| PHASPhaseBio Pharmaceuticals Inc | COM | 300,000 | $933.0K | 0.1% | History |
| Teligent, Inc.87960W203 | COM NEW | 1,069,465 | $426.7K | <0.1% | – |
| CCRNCross Country Healthcare Inc | COM | 20,000 | $424.8K | <0.1% | History |
| KRROKorro Bio, Inc. | COM | 30,000 | $211.8K | <0.1% | History |